Marc E. Wiles
Impact in
- Ophthalmology top 10%
- Retinal Diseases and Treatments
-
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms
Papers in
-
- Cancer therapeutics and mechanisms 2
-
- Neonatal Respiratory Health Research 3
- Chronic Obstructive Pulmonary Disease (COPD) Research 2
- Co-authors
- Darla Landfair (4 shared papers)Eric Lynam (3 shared papers)David Sheṕro (5 shared papers)Carol Bell (2 shared papers)Herbert B. Hechtman (4 shared papers)Nebojša Janjić (1 shared paper)Tammy L. Wagner (1 shared paper)William B. Weglicki (1 shared paper)
- Journals
- Drug Delivery (3 papers)Journal of Leukocyte Biology (2 papers)Life Sciences (1 paper)In Vitro Cellular & Developmental Biology - Animal (1 paper)Drug Discovery Today (1 paper)
- Partner nations
- United StatesCzechiaUnited Kingdom
In The Last Decade
Marc E. Wiles
14 papers receiving 298 citations
Peers
Comparison fields: 5 of 79
- Ophthalmology 27
- Immunology 52
- Immunology and Allergy 14
- Nutrition and Dietetics 35
- Nephrology 15
Countries citing papers authored by Marc E. Wiles
This map shows the geographic impact of Marc E. Wiles's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc E. Wiles with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc E. Wiles more than expected).
Fields of papers citing papers by Marc E. Wiles
This network shows the impact of papers produced by Marc E. Wiles. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc E. Wiles. The network helps show where Marc E. Wiles may publish in the future.
Co-authors
The 25 scholars most cited alongside Marc E. Wiles, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 85 | |
| 2 | 1996 | 38 | |
| 3 | 1991 | 34 | |
| 4 | 1993 | 25 | |
| 5 | 1990 | 19 | |
| 6 | 1997 | 19 | |
| 7 | 1994 | 19 | |
| 8 | Modulation of pulmonary permeability in vivo with agents that affect the cytoskeleton. | 1991 | 18 |
| 9 | 1998 | 17 | |
| 10 | 2018 | 16 | |
| 11 | 1992 | 14 | |
| 12 | 2001 | 7 | |
| 13 | 1999 | 4 | |
| 14 | 1999 | 3 |
About Marc E. Wiles
Marc E. Wiles is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Immunology, Physiology and Cardiology and Cardiovascular Medicine, having authored 14 papers that have together received 318 indexed citations. Recurring topics across this work include Neonatal Respiratory Health Research (3 papers), Cancer Treatment and Pharmacology (2 papers), Cancer therapeutics and mechanisms (2 papers), Nitric Oxide and Endothelin Effects (2 papers), Immune Response and Inflammation (2 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (2 papers), Chemotherapy-induced cardiotoxicity and mitigation (2 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (1 paper). The work is most often cited by research in Ophthalmology (27 citations), Immunology (52 citations), Immunology and Allergy (14 citations), Nutrition and Dietetics (35 citations) and Nephrology (15 citations). Marc E. Wiles has collaborated with scholars based in United States, Czechia and United Kingdom. Frequent co-authors include Darla Landfair, Eric Lynam, David Sheṕro, Carol Bell, Herbert B. Hechtman, Nebojša Janjić, Tammy L. Wagner, William B. Weglicki, Richard Welbourn and Nicole Morel. Their work appears in journals such as Drug Delivery, Journal of Leukocyte Biology, Life Sciences, In Vitro Cellular & Developmental Biology - Animal and Drug Discovery Today.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.